v3.24.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Treasury Stock Amount
Beginning balance (in shares) at Dec. 31, 2020   396,303 393,014        
Beginning balance at Dec. 31, 2020 $ 2,631,345 $ 40 $ 39 $ 5,067,135 $ (2,230,619) $ 83,534 $ (288,784)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares)   9,421          
Exercise of stock options 31,479 $ 1   31,478      
Stock-based compensation expense 683,293     683,293      
Purchase of capped call options (123,970)     (123,970)      
Equity consideration issued for acquisitions (in shares)   520          
Equity consideration issued for acquisitions 33,149     33,149      
Exercise of warrants (in shares)   337          
Exercise of warrants 9,205     9,205      
Purchase of treasury stock (in shares)   (323)          
Purchase of treasury stock (17,830)           (17,830)
Restricted stock unit vesting (in shares)   1,523          
Foreign currency translation (47,046)         (47,046)  
Other 2,098     2,098      
Net loss (1,523,195)       (1,523,195)    
Ending balance (in shares) at Dec. 31, 2021   407,781 393,014        
Ending balance at Dec. 31, 2021 $ 1,678,528 $ 41 $ 39 5,702,388 (3,753,814) 36,488 (306,614)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares) 15,102 3,267          
Exercise of stock options $ 8,743     8,743      
Stock-based compensation expense 578,799     578,799      
Equity consideration issued for acquisitions (in shares)   29,252          
Equity consideration issued for acquisitions 460,128 $ 3   460,125      
Purchase of treasury stock (in shares)   (1,560)          
Purchase of treasury stock (25,519)           (25,519)
Restricted stock unit vesting (in shares)   11,835          
Restricted stock unit vesting 1 $ 1          
Foreign currency translation 0            
Net loss (1,377,987)       (1,377,987)    
Ending balance (in shares) at Dec. 31, 2022   450,575 393,014        
Ending balance at Dec. 31, 2022 $ 1,322,693 $ 45 $ 39 6,750,055 (5,131,801) 36,488 (332,133)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares) 25,180 3,943          
Exercise of stock options $ 16,540     16,540      
Stock-based compensation expense 378,321     378,321      
Equity consideration issued for acquisitions 0            
Exercise of warrants (in shares)   153          
Exercise of warrants 4,942     4,942      
Purchase of treasury stock (in shares)   (3,211)          
Purchase of treasury stock (80,049)           (80,049)
Restricted stock unit vesting (in shares)   21,237          
Restricted stock unit vesting 1 $ 1          
Foreign currency translation 0            
Net loss (802,142)            
Ending balance (in shares) at Dec. 31, 2023   472,697 393,014        
Ending balance at Dec. 31, 2023 $ 840,306 $ 46 $ 39 $ 7,149,858 $ (5,933,943) $ 36,488 $ (412,182)